Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “Imatinib”
Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
ClinicalTrials.gov study NCT00786812. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL
ClinicalTrials.gov study NCT04722848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT02115672. IPD Sharing: Not stated. Countries: 1. Publications: 0.
5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk
ClinicalTrials.gov study NCT05385549. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib
ClinicalTrials.gov study NCT00117299. IPD Sharing: Not stated. Countries: 1. Publications: 0.
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
ClinicalTrials.gov study NCT00100997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors
ClinicalTrials.gov study NCT00611689. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib
ClinicalTrials.gov study NCT01475110. IPD Sharing: NO. Countries: 1. Publications: 0.
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00081133. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL
ClinicalTrials.gov study NCT00349518. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy
ClinicalTrials.gov study NCT05132738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00707408. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ ALCL
ClinicalTrials.gov study NCT02462538. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00686218. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer
ClinicalTrials.gov study NCT00041340. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
ClinicalTrials.gov study NCT00041990. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation
ClinicalTrials.gov study NCT00219726. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
ClinicalTrials.gov study NCT00905593. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)
ClinicalTrials.gov study NCT00135005. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study of Imatinib in Children With Neurofibromatosis and Airway Tumors
ClinicalTrials.gov study NCT03688568. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.